NEI
AMED

Northwest & Ethical Investments’s Amedisys AMED Stock Holding History

Northwest & Ethical Investments’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,965
Closed -$591K – 399
2021
Q3 		$591K Sell
3,965
-230
-5% -$47.8K 0.02% 333
2021
Q2 		$1.03M Sell
4,195
-4,029
-49% -$1.06M 0.03% 301
2021
Q1 		$2.18M Sell
8,224
-428
-5% -$121K 0.08% 257
2020
Q4 		$2.54M Hold
8,652
– – 0.1% 220
2020
Q3 		$2.05M Buy
8,652
+1,146
+15% +$261K 0.09% 236
2020
Q2 		$1.49M Buy
+7,506
New +$1.4M 0.07% 269

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Northwest & Ethical Investments's AMED Position: Q4 2021 in Review

Northwest & Ethical Investments sold out of Amedisys (AMED) in Q4 2021, closing a stake of 3,965 shares — an estimated $591K sold.

Northwest & Ethical Investments first reported a position in AMED in Q2 2020 and held it in 6 quarters. The position peaked at $2.54M in Q4 2020. 324 funds tracked by Wall St. Rank hold AMED as of Q4 2021.

  • Northwest & Ethical Investments reported no remaining Amedisys position as of Q4 2021 after selling out during the quarter.
  • Northwest & Ethical Investments sold 3,965 Amedisys shares in Q4 2021, an estimated $591K.
  • Northwest & Ethical Investments first reported a position in Amedisys in Q2 2020 and held it in 6 quarters.
  • Northwest & Ethical Investments's Amedisys position peaked at $2.54M in Q4 2020.
  • 324 funds tracked by Wall St. Rank held Amedisys as of Q4 2021.

Based on Northwest & Ethical Investments's 13F filing for Q4 2021, filed 9 Jul 2025.